Robert E. Mosser

Array ( [id] => 4644474 [patent_doc_number] => 08022080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Small molecules with antiprotozoal activity' [patent_app_type] => utility [patent_app_number] => 12/454046 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5286 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022080.pdf [firstpage_image] =>[orig_patent_app_number] => 12454046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552336 [patent_doc_number] => 08759384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Oxo-imidazolyl compounds' [patent_app_type] => utility [patent_app_number] => 12/454062 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8997 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12454062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5536123 [patent_doc_number] => 20090217928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Powder aerosolization apparatus and method' [patent_app_type] => utility [patent_app_number] => 12/387765 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9574 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20090217928.pdf [firstpage_image] =>[orig_patent_app_number] => 12387765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484921 [patent_doc_number] => 20090274686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'NUCLEOSIDE PHOSPHONATE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/434146 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32801 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274686.pdf [firstpage_image] =>[orig_patent_app_number] => 12434146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515440 [patent_doc_number] => 20090215747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES' [patent_app_type] => utility [patent_app_number] => 12/434270 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38402 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215747.pdf [firstpage_image] =>[orig_patent_app_number] => 12434270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8113787 [patent_doc_number] => 08158110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease' [patent_app_type] => utility [patent_app_number] => 12/433231 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9836 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158110.pdf [firstpage_image] =>[orig_patent_app_number] => 12433231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304171 [patent_doc_number] => 20090298823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Inhibitors of protein kinases' [patent_app_type] => utility [patent_app_number] => 12/386848 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 74216 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298823.pdf [firstpage_image] =>[orig_patent_app_number] => 12386848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480785 [patent_doc_number] => 20090203742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'BROADSPECTRUM 2-AMINO-BENZOTHIAZOLE SULFONAMIDE HIV PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/426730 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13107 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203742.pdf [firstpage_image] =>[orig_patent_app_number] => 12426730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404517 [patent_doc_number] => 20090239831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis' [patent_app_type] => utility [patent_app_number] => 12/386412 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16438 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 65 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239831.pdf [firstpage_image] =>[orig_patent_app_number] => 12386412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954250 [patent_doc_number] => 20110034478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs' [patent_app_type] => utility [patent_app_number] => 12/937881 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7072 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034478.pdf [firstpage_image] =>[orig_patent_app_number] => 12937881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392327 [patent_doc_number] => 20090209640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Prevention of and countermeasures against viral infection' [patent_app_type] => utility [patent_app_number] => 12/385667 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3885 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209640.pdf [firstpage_image] =>[orig_patent_app_number] => 12385667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380638 [patent_doc_number] => 20090192477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Method and kit for moisturizing the surface of the eye' [patent_app_type] => utility [patent_app_number] => 12/383935 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3002 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192477.pdf [firstpage_image] =>[orig_patent_app_number] => 12383935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571802 [patent_doc_number] => 08338448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Chemokine receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/414352 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50244 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12414352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367155 [patent_doc_number] => 20090304714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics' [patent_app_type] => utility [patent_app_number] => 12/411226 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 41812 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304714.pdf [firstpage_image] =>[orig_patent_app_number] => 12411226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458689 [patent_doc_number] => 20090258841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR SKIN CARE' [patent_app_type] => utility [patent_app_number] => 12/410318 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17285 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258841.pdf [firstpage_image] =>[orig_patent_app_number] => 12410318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386372 [patent_doc_number] => 20090227617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Esters Of Glucuronide Prodrugs Of Anthracyclines And Method Of Preparation And Use In Tumor-Selective Chemotherapy' [patent_app_type] => utility [patent_app_number] => 12/399569 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10233 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227617.pdf [firstpage_image] =>[orig_patent_app_number] => 12399569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570282 [patent_doc_number] => 20090253660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Minocycline Compounds and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/398980 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9089 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253660.pdf [firstpage_image] =>[orig_patent_app_number] => 12398980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196764 [patent_doc_number] => 20110028522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'FULLERENE THERAPIES FOR INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/921049 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7361 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028522.pdf [firstpage_image] =>[orig_patent_app_number] => 12921049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196764 [patent_doc_number] => 20110028522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'FULLERENE THERAPIES FOR INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/921049 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7361 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028522.pdf [firstpage_image] =>[orig_patent_app_number] => 12921049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196764 [patent_doc_number] => 20110028522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'FULLERENE THERAPIES FOR INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/921049 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7361 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028522.pdf [firstpage_image] =>[orig_patent_app_number] => 12921049 [rel_patent_id] =>[rel_patent_doc_number] =>)